Published on Atlas Magazine (https://www.atlas-mag.net)

Home > Printer-friendly

Sanofi vaccine to enter Phase III of clinical trials

Tweet [1] [2]
Magazine Issue: 
2020, what a waste! [3]
Magazine date: 
May 2021

vaccinOn 27 May 2021, the Sanofi laboratory announced the transition to large-scale trials of its Covid-19 vaccine. Phase III is used to evaluate the efficiency of the vaccine, which will be tested on 35 000 people in several countries, including the United States.

In a best-case scenario, Sanofi's vaccine could be marketed by the end of 2021, one year after the first Covid-19 vaccines became available.

Read also | Covid-19: the cost of global vaccination [4]

Fri, 28/05/2021 - 10:03

Source URL: https://www.atlas-mag.net/en/article/sanofi-vaccine-to-enter-phase-iii-of-clinical-trials

Links:
[1] https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.atlas-mag.net%2Fen%2Farticle%2Fsanofi-vaccine-to-enter-phase-iii-of-clinical-trials&text=Sanofi+vaccine+to+enter+Phase+III+of+clinical+trials
[2] https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.atlas-mag.net%2Fen%2Farticle%2Fsanofi-vaccine-to-enter-phase-iii-of-clinical-trials&source=Atlas Magazine&mini=true
[3] https://www.atlas-mag.net/en/issue/2020-a-lost-year
[4] https://www.atlas-mag.net/en/article/covid-19-the-cost-of-global-vaccination